FibroGen, Inc. (LON: 0IL8)
London
· Delayed Price · Currency is GBP · Price in USD
0.494
-0.057 (-10.37%)
Jan 22, 2025, 5:38 PM BST
FibroGen Revenue
FibroGen had revenue of $46.33M USD in the quarter ending September 30, 2024, with 15.45% growth. This brings the company's revenue in the last twelve months to $180.02M, up 16.15% year-over-year. In the year 2023, FibroGen had annual revenue of $147.75M with 4.99% growth.
Revenue (ttm)
$180.02M
Revenue Growth
+16.15%
P/S Ratio
n/a
Revenue / Employee
$370.40K
Employees
486
Market Cap
41.24M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 147.75M | 7.02M | 4.99% |
Dec 31, 2022 | 140.73M | -94.58M | -40.19% |
Dec 31, 2021 | 235.31M | 58.99M | 33.46% |
Dec 31, 2020 | 176.32M | -80.26M | -31.28% |
Dec 31, 2019 | 256.58M | 43.62M | 20.48% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |
FibroGen News
- 5 weeks ago - FibroGen started at buy by H.C. Wainwright - Seeking Alpha
- 5 weeks ago - FibroGen appoints David DeLucia CFO - Seeking Alpha
- 5 weeks ago - FibroGen Appoints David DeLucia as Chief Financial Officer - GlobeNewsWire
- 2 months ago - FibroGen, Inc. (FGEN) Q3 2024 Earnings Conference Call Transcript - Seeking Alpha
- 2 months ago - FibroGen Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - FibroGen to Report Third Quarter 2024 Financial Results - GlobeNewsWire
- 5 months ago - FibroGen, Inc. (FGEN) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 6 months ago - One Year, Five Trial Failures: FibroGen Terminates Pancreatic Cancer Treatment Program - Benzinga